Reimagine Care Revolutionizes Oncology with AI-Powered Remi Upgrade for Safer, Empathetic Patient Support

March 25, 2026
Reimagine Care Revolutionizes Oncology with AI-Powered Remi Upgrade for Safer, Empathetic Patient Support
  • Reimagine Care unveils a major evolution of Remi, its AI-powered oncology assistant, designed to deepen patient understanding, amplify empathy, strengthen safety protections, and better prepare care teams.

  • The update centers on oncology-native design tailored to cancer care journeys, deeper patient understanding through AI, expanded safety safeguards with continuous monitoring and clinical guardrails, and AI-assisted redesigns of care-team workflows.

  • Remi now facilitates more natural, sophisticated conversations by translating patient-reported symptoms into structured clinical insights and clear escalation steps when needed, powered by advanced AI and large language models.

  • The enhanced platform supports the Virtual Care Center model, helping oncology-trained clinicians quickly interpret conversations, manage symptoms, coordinate care, and reduce avoidable emergency department visits.

  • Industry context: with over two million new U.S. cancer cases annually, many patients experience symptoms at home between visits, and emergency department visits stay high due to gaps in timely support.

  • Consumer expectations for immediate, text-based, conversational AI are rising, and Remi aims to meet these in oncology by enabling patients to communicate in their own words and helping clinicians respond earlier and more thoughtfully.

  • Since its inception, Remi has supported over 10,000 patients and hundreds of thousands of interactions, highlighting its growing role in between-visit cancer care.

  • The expanded capabilities aim to support more parts of the cancer journey, including advanced therapies like CAR-T outside the hospital, as well as survivorship and end-of-life care.

  • About Reimagine Care: the company provides an AI-enabled virtual care platform that augments rather than replaces human clinicians, targeting 24/7 access and resolution of 95% of patient needs virtually to reduce after-hours physician burden.

  • CEO Dan Nardi emphasizes the need for rapid, responsive oncology care akin to other on-demand services.

  • (Note: Repeated point consolidated in the opening; the core message remains the major evolution of Remi to support faster, safer, patient-centered oncology care.)

Summary based on 1 source


Get a daily email with more AI stories

More Stories